Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Manish BAnker
Eligibility
Inclusion criteria
Inclusion criteria: This is a retrospective cohort study of all patients seeking treatment using Assisted Reproductive Technology at a single tertiary fertility center, Nova IVF Fertility, Ahmedabad, India during the Covid-19 pandemic. Control population included women undergoing similar ART treatment type in the precovid time (1st Oct 2019, to 31st March 2021).
Exclusion criteria
Exclusion criteria: All women screened positive for Covid 19 as per ICMR guidelines for ART resumption ALL IVF cycles using donor eggs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study was to evaluate both the prevalence of COVID-19 and the efficacy of a universal COVID-19 screening program in patients undergoing COS. Safety was measured using SARS-CoV-2 PCR positivity during ART cycles, COVID-related cycle cancellation rates, and adverse materno-fetal outcomes during pregnancy.Timepoint: 1 yr | — |
Secondary
| Measure | Time frame |
|---|---|
| . Secondary clinical outcomes included comparison of prematurity rates, perinatal morbidity and maternal morbidity and mortality rates.Timepoint: 1 year | — |
Countries
India
Contacts
Public Contactparul arora
Nova IVF Fertility
Outcome results
None listed